Osteoclast stimulating and differentiating factors in human cholesteatoma

Laryngoscope

Volumn 113, Issue 3, 2003, Pages 436-442

  Hamzei, Michael ^a   Ventriglia, Giovanni ^a   Hagnia, Mitra ^a   Antonopolous, Alexandra ^a   Bernal Sprekelsen, Manuel ^b   Dazert, Stefan ^a   Hildmann, Henning ^a   Sudhoff, Holger ^a,c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF BARCELONA   (Spain)

^c St Elisabeth Hospital Bochum   (Germany)

Author keywords

Activated T cells; Cholesteatoma; Osteoclastogenesis; Osteoprotegerin

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTHRITIS; ARTICLE; CHOLESTEATOMA; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD11A; ANTIGENS, CD14; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AVIAN PROTEINS; BONE RESORPTION; CARRIER PROTEINS; CHOLESTEATOMA, MIDDLE EAR; CULTURE TECHNIQUES; CYTOKINES; DNA PRIMERS; DNA, COMPLEMENTARY; EYE PROTEINS; GLYCOPROTEINS; HUMANS; INTEGRIN ALPHAV; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 0037336164     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200303000-00009     Document Type: Article

References (24)

1. Chole RA. The molecular biology of bone resorption due to chronic otitis media. Ann N Y Acad Sci 1997;830:95-109.
2. Michaels L, Hellquist HB. Ear, Nose and Throat Histopathology. London, Heidelberg, New York: Springer, 2001.
3. Chole RA. Bone resorption in aural cholesteatoma. In: Tos M, ed. Proceedings of the Fourth International Conference on Cholesteatoma and Mastoid Surgery. Kugler Publications, 1993.
4. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis. Nature 1999;397:315-323.
5. Roodman GD. Cell biology of the osteoclast. Exp Hematol 1999;27:1229-1241.
6. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-1508.
7. Cheshire IM, Blight A, Ratcliffe WA, Proops DW, Heath DA. Production of parathyroid-hormone-related protein by cholesteatoma cells in culture. Lancet 1991;338:1041-1043.
8. Bujia J, Kim C, Ostos P, Sudhoff H, Kastenbauer E, Hultner L. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol 1996;253:252-255.
9. Sudhoff H, Hildmann H, Michaels L. Cholesteatoma: pathogenesis. In: Ars B, ed. Pathogenesis in Cholesteatoma. The Hague: Kugler Publications, 1999:79-104.
10. Greenfield EM, Bi Y, Miyauchi A. Regulation of osteoclast activity. Life Sci 1999;65:1087-1102.
11. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
12. Huang L, Xu J, Wood DJ, Zheng MH. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol 2000;156:761-767.
13. Hsu SM, Rainc L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immuno-peroxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
14. Yu CE, Oshima J, Wijsman EM, et al. Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group. Am J Hum Genet 1997;60:330-341.
15. Negri B, Schilling V, Bujia J, Schulz P, Kastenbauer E. Immunotype findings in macrophages in aural cholesteatomas. Eur Arch Otorhinolaryngol 1992;249:87-90.
16. Chole RA. Osteoclasts in chronic otitis media, cholesteatoma, and otosclerosis. Ann Otol Rhinol Laryngol 1988;97:661-666.
17. van Dijk CM, Visser CE, Veldman JE. Spatial distribution of Langerhans' cells and T-lymphocyte subpopulations in human tympanic membrane and aural cholesteatoma. Virchows Arch B 1986;52:143-152.
18. Cinamon U, Kronenberg J, Benayahu D. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma. Laryngoscope 2000;110:1198-1203.
19. Quinn J, Neale S, Fujikawa Y, McGee J, Athanasou N. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int 1998;62:527-531.
20. Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. J Bone Miner Metab 2000;18:177-184.
21. Udagawa N, Takahashi N, Jimi E, et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappaB ligand. Bone 1999;25:517-523.
22. Gyda M, Corisdeo S, Zaidi M, Troen B. Macrophage colonystimulating factor suppresses osteoblast formation. Biochem Biophys Res Commun 2001;285:328-334.
23. Quinn J, McGee J, Athanasou N. Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. J Pathol 1998;184:31-36.
24. O'Brien EA, Williams JH, Marshall MJ. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria. Biochem Biophys Res Commun 2000;274:281-290.